Back

Prognostic implication of tolvaptan in acute heart failure patients with renal dysfunction - Insights from AQUAMARINE Study -

28 August 2016 (08:30 - 12:30)
Organised by:
Congress Presentation Part of: Poster session 2 - Heart failure / LV dysfunction Prognosis ESC Premium Access ESC Congress 2016

About the speaker

Photo
Doctor Yuta Sudo

Soka Municipal Hospital, Soka (Japan)

49 More presentations in this session

Presentation thumbnail
Doctor J. Parissis (Athens, GR)
Abstract
Presentation thumbnail
Doctor Y. Chen (Taipei, TW)
Abstract
Presentation thumbnail
Doctor C. De Pasquale (Messina, IT)
Abstract Slides
Presentation thumbnail
Doctor K. Alhabib (Riyadh, SA)
Abstract Slides
Presentation thumbnail
Doctor P. Freitas (Carnaxide, PT)
Abstract

Access the full session

Session thumbnail
Poster session 2 - Heart failure / LV dysfunction

The Event

Event poster

ESC Congress 2016

28 August 2016 08:30 CET

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources